← Open Payments lookup

RHONDA CHOI: Open Payments

NPI 1013428366 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,188 in 105 payments from 15 companies in 2025. Trend: 2023 $94 · 2024 $2,981 · 2025 $2,188

Food & beverage: $2,093Education: $95
CompanyPaymentsAmount
ABBVIE INC.52$994
Janssen Biotech, Inc.13$302
Takeda Pharmaceuticals U.S.A., Inc.11$235
Ferring Pharmaceuticals Inc.4$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$103
Aimmune Therapeutics, Inc.4$86
Regeneron Healthcare Solutions, Inc.3$74
Phathom Pharmaceuticals, Inc.5$69
Madrigal Pharmaceuticals2$58
Novo Nordisk Inc2$37

Products named: RINVOQ, LINZESS, TREMFYA, ENTYVIO, CREON, SKYRIZI, REBYOTA, ZENPEP.

Industry payments across TX — which companies pay providers there.